Prior authorization required per Nebraska DHHS and COE requirement

Bariatric procedures for Nebraska members must meet Nebraska DHHS medical necessity criteria (Nebraska Administrative Code § 471-18) and be performed at a Bariatric Surgery Center of Excellence per NAC requirements; prior authorization should reference these state-specific rules when requesting coverage.

Authorize device-based therapy with documented duration and adjunct program

Document device-specific treatment duration and adjunctive program participation for endoscopic devices and balloons: the TransPyloric Shuttle is approved for up to 12 months of therapy and intragastric balloons have a standard 6-month placement period; prior authorization should state intended device, planned duration, BMI indication, and that use is adjunctive to diet/behavior programs.

• TransPyloric Shuttle: 12-month treatment duration and intended for BMI 35.0–40.0 kg/m2 or 30.0–34.9 kg/m2 with comorbidity (used with diet/behavior modification) [[24]]
• Intragastric balloons (e.g., Orbera): maximum placement period of 6 months and intended as adjunct to long-term supervised diet and behavior modification [[29],[141]]

Document prior surgery and clinical justification for revisional operations

For revisional procedures include documentation of the prior bariatric operation and a clear rationale for revision—identify prior procedure type, prior attempts at nonoperative correction (e.g., band manipulation/adjustment), and the specific technical failure or major complication prompting revision.

• Specify prior procedure (e.g., LAGB, sleeve gastrectomy, RYGB) and timeline.
• Document attempts to correct problems nonoperatively (records must show manipulation/adjustment attempted for band slippage).
• State the complication/indication for revision (e.g., erosion, leak, obstruction, staple-line failure, uncontrollable reflux meeting criteria).

No explicit prior authorization codes/requirements listed in these excerpts

The policy excerpts do not list explicit prior authorization CPT codes or step-by-step authorization requirements; providers should follow usual plan prior-authorization processes and include clinical documentation referenced elsewhere in the policy.

Prior authorization: document prior weight-loss attempts and evidence for novel procedures

Require documentation of prior conservative weight-loss efforts and a rationale when requesting authorization for novel or less-proven procedures; the policy notes limited long-term data for many newer endoscopic and single-anastomosis procedures and expects demonstration of prior therapy failure.

• Document prior multidisciplinary conservative therapies (diet, exercise, behavior modification, pharmacologic therapy when appropriate).
• Explain rationale for selecting investigational/less-proven procedure over standard surgical options.

Prior authorization: confirm indication and prior conservative treatment

Confirm the patient meets device- or trial-specific selection criteria and has failed conservative therapy before authorization—pivotal device trials used specific BMI/comorbidity thresholds that should align with the requested indication.

• Reference trial-consistent BMI/comorbidity eligibility (e.g., REDUCE trial BMI ranges for dual-balloon; ReCharge trial BMI examples for vagal blocking).
• Include documentation of failure of conservative therapies as required by trial-aligned selection.

Prior authorization: document multidisciplinary care and preoperative assessment

Document multidisciplinary preoperative care for authorization decisions: include records of dietary therapy, physical activity counseling, behavioral modification, and pharmacologic therapy when applicable, plus a comprehensive preoperative assessment per society guidance.

• Obesity-focused history and detailed weight history.
• Evidence of diet, activity, and behavioral interventions with follow-up.
• Documentation of pharmacologic therapy trials when appropriate.

Document device FDA indication and program/monitoring plans

For FDA‑cleared devices and device programs, document device indication, labeled use, and the plan for supervised diet/behavior programs and monitoring; cite FDA labeling where applicable (e.g., Orbera indications) in the authorization request.

• Confirm device labeling and intended patient BMI range (e.g., Orbera: BMI ≥30 to ≤40; TransPyloric Shuttle: BMI 35.0–40.0 or 30.0–34.9 with comorbidity).
• Document plan for long-term supervised diet and behavior modification and informed consent about device risks.

Prior authorization not specified in this references segment

No additional prior authorization guidance is provided in the referenced segment; follow plan processes and include the medical-record documentation specified elsewhere in the policy.

Prior authorization/billing note: CPT code 43889 was added

CPT code 43889 (endoscopic sleeve gastroplasty) was added to the applicable codes list; include this code in authorization and billing requests when ESG (ESG/ESG with OverStitch) is planned.

• Use CPT 43889 for transoral, endoscopic sleeve gastroplasty when applicable (policy added this code to the applicable list).

Conservative therapy required prior to surgery

Authorization for bariatric surgery typically requires documentation that multidisciplinary conservative therapies (dietary therapy, physical activity, behavior modification, and medication management when appropriate) have been attempted and were unsuccessful prior to surgery.

• Summarize prior nonsurgical interventions and duration in the record.
• Document adherence or reasons why conservative therapy was insufficient.

Conservative therapy expected first-line

First-line conservative treatments are expected before considering surgical intervention; authorization should include documentation of dietary therapy, physical activity, behavior modification, and trials of medication management as applicable.

Assess and document non-surgical contributors before revisional surgery

Before approving revisional surgery, assess and document non‑surgical contributors to failure—evaluate behavioral factors (e.g., eating patterns, adherence), psychiatric comorbidity, and medical causes to ensure revision addresses anatomic rather than behavioral causes.

• Document assessment of eating/lifestyle behaviors and mental health status.
• Explain why anatomical revision is appropriate versus further behavioral interventions.

Step therapy not specified in these excerpts

No step therapy (formal sequencing/authorization steps) is specified in these policy excerpts; providers should document prior conservative care but there is no explicit step-therapy program listed here.

Step-therapy/follow-up plan expected for intragastric balloons

For intragastric balloon authorization consider requiring a documented plan for follow-up and long-term management because weight loss is often transient after removal; include a plan for subsequent behavioral or pharmacologic therapy or consideration of surgery.

• Document follow-up plan after balloon removal and intended long-term weight-maintenance strategy.
• Confirm prior failure of conservative strategies before IGB placement.

Guidelines: conservative multidisciplinary therapy recommended first

Professional guidelines recommend multidisciplinary conservative interventions as the initial approach; authorization for surgery or devices should include documentation that these interventions were provided and unsuccessful.

Document multidisciplinary non-surgical therapy prior to surgery

Document non-surgical therapy trials before surgery: include supervised dietary programs, physical-activity counseling, behavioral modification, and pharmacotherapy when appropriate as part of the preoperative record.

• List specific programs or clinicians involved and duration of participation.
• Record response and adherence to these interventions.

Require documentation of failed conservative therapy prior to IGB

Specify prior conservative management prior to placement of an intragastric balloon: Orbera and similar FDA‑cleared systems are indicated as adjuncts after failure of conservative strategies and must be used with a supervised diet/behavior program.

• Document prior supervised diet, exercise, and behavior modification attempts.
• Confirm patient meets device labeling BMI criteria and understands device time‑limited use (6 months).

Step therapy not described in this references segment

The references segment does not describe a formal step-therapy program; where required, follow the policy's general expectation for documenting prior conservative care and guideline-aligned evaluations.

Medical-record documentation must fully support medical necessity

Medical records must contain legible documentation supporting medical necessity: include relevant medical history, physical examination, and results of pertinent diagnostic tests or procedures; records must be made available upon request.

• Include detailed weight history, prior interventions, and objective diagnostic results.
• Ensure documentation is legible and retained in the medical record for review.

Pre-revisional documentation must show multidisciplinary assessment and anatomic evaluation

Pre-revisional documentation should reflect a thorough multidisciplinary assessment addressing anatomic causes of inadequate weight loss or weight regain and postoperative behavioral factors before approval for revisional surgery.

• Document imaging or endoscopic findings that identify anatomical causes.
• Summarize multidisciplinary team input and rationale for revision.

Include detailed prior-procedure history and reasons for revision

For revisional cases include required clinical history: prior bariatric procedure type, specific reasons for failure (medical vs behavioral), comorbidities, and prior weight-loss attempts and trajectories to justify the revisional operation.

• State the index operation, dates, and complications.
• Provide objective data on weight trajectory and prior management steps.

Document procedural standardization and surgeon training where relevant

When authorization is for procedures evaluated in randomized trials, documentation should reflect procedural standardization and surgeon training as applicable (trial protocols required standardized laparoscopic procedures performed by trained bariatric surgeons).

• Indicate surgeon experience and any specialized training relevant to the procedure.
• Note adherence to standardized procedural steps when relevant to safety/effectiveness.

Document DJBL (EndoBarrier) indication, informed consent, and monitoring plan

For duodenal-jejunal bypass liners (DJBL / EndoBarrier) authorization and follow-up should document indication, informed consent about device risks, and planned monitoring because studies report notable early removal rates and serious adverse events.

• Document counseling on device risks (migration, GI hemorrhage, obstruction, hepatic abscess) and plan for AE monitoring.
• Provide plan for timely device removal and postoperative follow-up.

Document comprehensive preoperative obesity-focused evaluation and testing

Preoperative evaluation documentation should include an obesity-focused history, detailed weight history, prior weight-loss attempts, and relevant laboratory and diagnostic testing as part of comprehensive assessment for surgical authorization.

• Include causative factors (medication, family history), prior program participation, and greatest duration of weight loss and maintenance.
• Document pertinent labs and diagnostics used to assess surgical risk and comorbidities.

Preoperative evaluation: include exam, labs, detailed weight history, and rationale for preop weight loss when applicable

Expanded preoperative documentation expectations: include physical exam, labs/diagnostics, detailed weight history, and documentation of consideration of preoperative weight loss when it may improve technical aspects of surgery.

Pediatric MBS: document multidisciplinary evaluation and psychosocial assessment

Pediatric MBS authorization requires multidisciplinary assessment and documentation of psychosocial evaluation, family stability, Tanner stage (when applicable), and near-final adult height per pediatric guidance before approval.

• Document Tanner stage and near-final height when relevant.
• Include psychological evaluation confirming family stability and patient adherence ability.

References-only segment provides no new documentation obligations

References do not specify additional documentation requirements beyond those already noted; include cited bibliographic materials only for informational support in the record if relevant.

Medical records may be requested to verify medical necessity

Medical records supporting authorization may be requested; ensure records fully support medical necessity and include relevant history, examination, and diagnostic test results in legible form.

Denial risk: insufficient medical-record documentation

Lack of adequate medical-record documentation that supports medical necessity may result in denial of requested services; include all required clinical details to mitigate denial risk.

• Ensure documentation is legible, complete, and available upon request.

Denial risk for inadequate multidisciplinary assessment before revision

Failure to document a thorough multidisciplinary assessment and individualized risk–benefit consideration before revisional bariatric surgery could lead to coverage denial.

• Provide multidisciplinary team notes and rationale addressing anatomical vs behavioral causes of failure.

Denial risk: reoperation/conversion rates require justification

High rates of reoperation and conversions after some index procedures (notably LAGB) mean prior authorization requests for revision must justify the chosen revisional approach with prior-procedure history and complication data to avoid denials.

• Document prior procedure outcomes and why conversion or correction is preferred over alternative options.

Denial risk: limited ESG evidence may trigger noncoverage

Limited evidence for Endoscopic Sleeve Gastroplasty (OverStitch) may lead to noncoverage or additional scrutiny; authorization should include strong supporting documentation when ESG is requested.

• Include trial evidence, patient selection justification (matching trial populations), and plan for long-term follow-up.

Denial risk: evidence limitations (loss to follow-up, lack of comparative data)

Cases with inadequate evidence (high loss to follow-up, insufficient comparative data, or lack of long‑term outcomes) may be at risk for denial; supply complete outcome and follow-up data when seeking authorization for devices/procedures with limited evidence.

• Provide long-term follow-up data if available and rationale for expected benefit despite evidence gaps.

Denial risk: avoid mandatory preoperative weight-loss requirements without justification

No randomized trial evidence supports mandatory preoperative weight loss; avoid imposing absolute preoperative weight‑loss mandates without clinical justification, as this could risk inappropriate denials inconsistent with guideline statements.

Denial risk: age-based contraindication for adjustable gastric bands

Adjustable gastric bands are contraindicated in patients under 18 per FDA labeling; prior authorization for band procedures must document age and labeled indications to avoid contraindication-based denial.

No additional authorization rules in references-only segment

This references-only policy segment does not provide additional authorization triggers; rely on the policy's clinical criteria and state/contractual rules for authorization decisions.

Coverage governed by federal/state/contract rules; documentation does not guarantee coverage

Coverage decisions are governed by federal, state, or contractual requirements; failure to provide complete documentation supporting medical necessity may result in denial and documentation does not guarantee coverage.